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Abstract
Background: Emergency Departments (ED) have a high flow of patients and time is often crucial. New
technologies for laboratory analysis have been developed, including Point of Care Technologies (POCT), which can
reduce the transport time and time of analysis significantly compared with central laboratory services. However,
the question is if the time to clinical action is also reduced if a decisive laboratory answer is available during the
first contact between the patient and doctor. The present study addresses this question: Does a laboratory answer,
provided by POCT to the doctor who first attends the patient on admission, change the time to clinical decision in
commonly occurring diseases in an ED compared with the traditional service from a central laboratory?
Methods: We performed a randomised clinical trial with parallel design and allocation ratio 1:1. The eligibility
Criteria were: All patients referred from General Practitioner or another referring doctor suspected for a deep
venous thrombosis (DVT), acute coronary syndrome (ACS), acute appendicitis (AA) or acute infection (ABI). The
outcome measure was the time spend from the blood sample was taken to a clinical decision was made.
Results: The study period took place in October–November 2009 and from February to April 2010. 239 patients
were eligible for the study. There was no difference between the groups suspected for DVT, ACS and AA, but a
significant reduction in time for the ABI group (p:0.009), where the median time to decision was reduced from 7
hours and 33 minutes to 4 hours and 38 minutes when POCT was used. Only in the confirmation of ABI the time
to action was significantly shorter.
Conclusions: Fast laboratory answers by POCT in an ED reduce the time to clinical decision significantly for
bacterial infections. We suggest further studies which include a sufficient number of patients on deep venous
thrombosis, acute appendicitis and acute coronary syndrome.
Background
The Emergency Departments (ED) are characterized by
a high flow of patients with a broad range of different
conditions and timely delivery of services is crucial to
avoid congestion. In order to achieve a reduction in
length of stay every step from admission to discharge
must be optimized, including a reduction in waiting
time for laboratory results.
New technologies for laboratory analysis have been
developed, including Point of Care Technologies
(POCT) [1]. These technologies ought to be faster and
easier to use than the standard central laboratory, and
still have a comparable quality of the results [2]. Such
technologies are increasingly available and can reduce
the transport time and time of analysis significantly
compared with central laboratory services [3-5].
In an ED a plan of treatment for the patient often
depends on a laboratory answer. In some cases a labora-
tory test directly determines the next step of a plan. The
result of D-dimer guides the decision, if a patient sus-
pected for deep venous thrombosis should have an ultra-
sonography scan of the leg performed [6]. For a patient
with chest pain and a normal ECG the result of Troponin
and Creatin Kinase directs the clinical action [7]. In other
cases the laboratory results might be supportive for a
clinical decision, like the CRP result to decide if a patient
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treatment [8] or a patient, suspected for acute appendici-
tis should be operated [9].
A time reduction from a blood test is requested to the
answer is available might be important. However, the
crucial question is, if the time to clinical action is also
reduced if a decisive laboratory answer is available during
the first contact between the patient and doctor. Several
other factors might influence, like interpretation of the
laboratory result to the clinical presentation, the doctors
level of experience, time allowed to attend the patient
and waiting time for other investigations [10]. The pre-
sent study addresses this question: Does a laboratory
answer, provided by POCT to the doctor who first
attends the patient on admission, change the time to clin-
ical decision in commonly occurring diseases in an ED
compared with the traditional service from a central
laboratory?
Methods
Design
We performed a randomised clinical trial with parallel
design and allocation ratio 1:1. The eligibility Criteria
were: All patients referred from General Practitioner or
another referring doctor suspected for a deep venous
thrombosis (DVT), acute coronary syndrome (ACS), acute
appendicitis (AA) or acute infection (ABI). These groups
were chosen since they are common in the ED, and the
clinical decision to be taken depends more or less on a
laboratory tests. Even though most surgeons agree that the
diagnosis of appendicitis is not very dependent on the CRP
value, the result of inflammatory variables has a discrimi-
natory value [9]. Appendicitis was included in the study,
as it was an experience in the Kolding ED that most deci-
sions on this diagnosis were made after the results of CRP
were available.
The exclusion criteria were suspicion of ACS with ECG
changes which demanded immediate clinical action (like
ST-elevation) or other acute pathological ECG findings
or previous ACS; suspicion of AA and ABI where the
condition requires immediate action (like signs of severe
peritonitis, severe sepsis or meningitis). The outcome
measure was the time spend from the blood sample was
taken to a clinical decision was made. The clinical deci-
sion was defined as follows: for DVT the decision of
referring for ultrasonography or rejection of the suspi-
cion of DVT; for the suspicion of ACS: the diagnosis was
confirmed and the patient transferred to coronary care
unit, or the ACS suspicion rejected; for the suspicion of
AA: the decision of an operation or the diagnosis of AA
rejected; for the suspicion of ABI: the decision of pre-
scribing an antibiotic or the rejection of a bacterial cause
of the infection. The time of decision was reported in
minutes and was the time in the electronic patient file,
which first indicated that a decision was made, either by
a notice from a physician or nurse, a prescription of med-
icine or operation, a transfer to a coronary care unit or a
request for ultrasonography.
There were four blocks of randomisation numbers,
one for each diagnosis. For each diagnosis 48-52% were
even numbers and used for the POCT analysis.
Location
The study took place at the ED at Kolding Sygehus,
Denmark. The ED received around 9.000 patients
annually for admission with surgical, medical, cardiologi-
cal or ortopaedic conditions. All patients were referred
from a GP or another doctor outside the hospital.
Four research assistants were responsible for inclusion,
registration, POCT- analysis and registration of outcome.
The study was only opened for inclusion when one of the
research assistants was available. The decisive blood test
was D-Dimer for DVT, Troponin I and Creatin kinase-
(CK-MB) for ACS (Troponin T at the central laboratory),
and CRP for AA and ABI.
The POCT- analysis was performed in the AQT-90
(Radiometer). The AQT-90 is developed for high quality
laboratory test and utilises a time-resolved fluorescence
method to detect complexes formed between capture anti-
bodies, fluorescent tracer antibodies, and the antigen of
interest. The results are available after 15-20 minutes
depending on the parameter analyzed. The AQT-90 analy-
sis for TnI has been shown to be marginally inferior to
two laboratory assays in diagnosing AMI [10], and com-
parable to standard laboratory assays in analysis of
D-dimer for DVT [11].
All patients with suspected ACS 3 consecutive normal
analysis of troponin were required before the diagnosis
was rejected. Analysis of TnI at AQT-90 was only per-
formed the first time, while the second and third analysis
was ordered 6 and 12 hours after the admission from the
central laboratory.
The Central laboratory used Modular E1-170 (Roche
Diagnostics) for analysis of the blood samples. The
results are available after 1-2 hours.
When a patient was referred with one of the presumed
diagnosis of interest, the study assistant was called and
performed the randomisation to POCT-analysis (interven-
tion group) or to the standard central laboratory (control
group). When the laboratory assistant draw the blood
sample, the study assistant performed the POCT- analysis
if the patient was randomised to POCT-arm, otherwise
the blood sample was transferred to the central laboratory.
The physician, who admitted the patient, received the
POCT laboratory test answer slip from the research assis-
tant during the admission procedure. The answers from
the central laboratory appeared in the electronic patient
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trace the results in the file.
The admitting physician was normally an ED employed
doctor, often newly graduated and with few months of
experience. A range of specialist was available for consul-
tation at all times.
Statistics and ethics
The sample size calculation estimated 2 × 35 patients for
each diagnose, assuming a time to decision of 240 min-
utes, with a SD of 60 minutes, a 1% risk of type I error
and 5% risk of type II error and a minimum relevant dif-
ference of 60 minutes between the two groups.
All results were recorded on preprinted forms, trans-
ferred to electronic form by using Epidata 3.1. and ana-
lyzed in STATA version 7. Continuous data are presented
as medians with inter-quartile ranges and compared with
the non-parametric Mann-Whitney U -test. Categorical
data are presented with a number and percentage of
occurrences and compared with Fishers exact test.
After contact to the regional ethic committee, no
approval was required for this study. Since it was a study
of a working method, not related to any contact with the
patient or included any additional test to the routine for
the patient, no information to the patient or consent was
required nor registration at a public trial registry. The
study was registered at the Danish Data Protection Agency
(J.nr. 2009-41-3923).
Results
The study took place in October–November 2009, and
from February to April 2010. 239 patients were eligible for
the study. The mean age of the patients in the POCT
group was 50.9 years versus 51.5 years in the central
laboratory group (p: 0.83) and 58% were females in the
POCT group versus 42% in the control group, a non-
significant difference (p: 0.08). The randomisation time of
the day was equally distributed in both groups (p: 0.26).
Seven patients were excluded because a definite endpoint
could not be identified.
The distribution between the different randomised
groups is shown in Figure 1.
In table 1 the time to clinical action is calculated.
There was no difference within the groups suspected for
DVT, ACS and AA, but a significant reduction in time
for
the ABI group (p:0.009), where the median time to
decision was reduced from 7 hours and 33 minutes to 4
hours and 38 minutes when POCT was used.
In table 2 the time to rejected or confirmed diagnosis
is calculated, depending on the laboratory technology
used. Only in the confirmation of ABI the time to action
is significantly shorter when POCT is used.
Discussion
We found a significant reduction in time to action of
approximately 3 hours for patients suspected for acute
bacterial infection. It was for the confirmed diagnosis of
ABI that the POCT reduced the time to decision. It was
not possible to reach a conclusive number of patients
for the AA, DVT and ACS groups. For AA there was a
non-significant tendency for the POCT analysis to
increase the time to decision.
An acute bacterial infection has often developed for
days at the time of admission, and is accompanied with
obvious focal sings of infection. It is possible for even a
newly graduated doctor to make decisions about anti-
biotic treatment for the majority of cases suspected for
a bacterial infection with a confirmatory CRP result.
In the diagnosis of appendicitis observation time is
important and repeated abdominal examinations are
often necessary. Diagnosing appendicitis requires long
experience and clinical skills beyond the level of a newly
graduated ED doctor and the diagnose is not dependent
on the CRP result alone [9].
Several other recent POCT studies have been reported,
especially on the suspicion of ACS. In a French rando-
mised study similar to ours, it was found that POCT in
an emergency department reduced the time to anti-
ischaemic therapy significantly, but not the length of stay
in the ED in the hands of emergency physicians [12].
Singer AJ et al (2008) reported similar results from US
[13] while a pre- post POCT study from Boston (2003)
showed a non-significant reduction in length of stay for
cardiac markers if measured by POCT [14]. However, we
did not find a study which compared a range of different
high quality POCT results with the time to clinical action
in an ED comparable to a Danish setting.
The study was weakened by the number of patients
participating, which was too low to reach conclusions
on some of the diagnosis of interest with a risk of type
II error. The pre-study power calculation was based on
clinical assumption of the time to diagnosis, which were
too optimistic and the standard deviation showed to be
far longer than the estimated 60 minutes.
We performed randomisation but had no clinical data
reflecting if the groups were clinically comparable,
which might not be the case in small groups and hence
introduce an incidental skewness. Despite the randomi-
sation procedure aimed at a distribution between the
two groups of 48-52% almost 67% of the 29 DVT sus-
pected patients’ blood tests were examined in the cen-
tral laboratory. This might have added to the skewness
in the group. For the patients suspected for ACS 3
blood samples were taken with 6 hours interval to
exclude ACS. Only the first blood sample was analysed
on the POCT because it is not necessary to use POCT
Mogensen et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2011, 19:49
http://www.sjtrem.com/content/19/1/49
Page 3 of 6Randomised  (n = 239)
DVT 30
ACS 57
AA 61
ABI 91 
Allocated to POCT (n = 109)
DVT 10
ACS 22
AA 29
ABI 48
Allocated to Central laboratory (n = 120)
DVT 20
ACS 25
AA 32
ABI 43
Analysed (n = 107)
DVT 10
ACS 22
AA 27
ABI 48
Excluded 2
Analysed (n = 115)
DVT 19
ACS 23
AA 30
ABI 43
Excluded 5
Figure 1 Flow diagram for the trial.A b b r i v a t i o n s :P O C T :p o i n to fc a r et e c h n o l o g y ;D V T: deep venous thrombosis; ACS: acute coronary
syndrome; AA: acute appendicitis; ABI: acute bacterial infection.
Table 1 Central laboratory vs POCT: time to action in an Emergency Department
Condition group number median (minutes) p25 (minutes) p75 (minutes) p-value*
Observation for deep venous thrombosis (DVT) central lab. 19 282 183 425 0.91
POCT 10 316 180 477
difference 34
Observation for acute coronary syndrome (ACS) central lab. 23 757 365 1285 0.75
POCT 22 708 217 1226
difference -49
Observation for acute appendicitis (AA) central lab. 30 207 137 388 0.98
POCT 27 247 130 384
difference 40
Observation for acute bacterial infection (ABI) central lab. 43 453 257 1127 0.009
POCT 48 278 123 598
difference -175
*Mann- Whitney test
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Page 4 of 6Table 2 time to action in confirmed and rejected diagnosis
condition diagnosis group number median time (minutes) p25 (minutes) p75 (minutes) p-value*
Observation for deep venous thrombosis (DVT) confirmed Central lab. 3 313 273 344 0.14
POCT 2 354 344 366
difference 41
rejected Central lab. 16 273 166 428 0.81
POCT 8 242 121 504
difference -31
Observation for acute coronary syndrome (ACS) confirmed Central lab. 2 1566 365 2767 0.12
POCT 2 188 158 217
difference -1378
rejected Central lab. 21 757 422 1264 0.86
POCT 20 853 483 1248
difference 96
Observation for acute Appendicitis (AA) confirmed Central lab. 4 185 119 261 0.87
POCT 8 214 123 309
difference 29
rejected Central lab. 26 234 137 415 0.85
POCT 19 251 171 478
difference 17
Observation for acute bacterial infection (ABI) confirmed Central lab 31 399 257 972 0.02
POCT 34 237 115 489
difference -162
rejected Central lab 12 929 247 1441 0.23
POCT 14 281 156 743
difference -648
* Mann-Whitney test
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6for a test which is taken as a routine or planned to be
taken several hours after admission. Since the majority
of ACS suspected patients needs two or three laboratory
tests before a conclusion can be made, POCT will only
be of limited value in these cases.
The study was interrupted around December- January
for both groups. We do not believe that this had any
impact on the results of the study. The study was not
blinded, which might influence on the involved physicians
decisions and recording of their decisions. The POCT
answers were given directly to the physician caring for the
patient, while it was the physician who had to trace the
central laboratory result in the patient- file. This might
give an additional delay in the time to action for the con-
trol group. However, the advantage of the POCT is not
only short time of analysis but also the immediate access
to the results.
The endpoint in this study was sometimes difficult to
define, e.g. the time when an action was taken or a sus-
pected diagnosis was rejected. However, it reflects the real
life situation, and the problem is equally distributed in
both the POCT and the control group, since it is not
related to the laboratory technique.
In this study a study assistant without other assignments
handled the POCT analysis. In real life a staff member
might have other assignments in addition to the POCT
analysis, which will prolong the time to the POCT answer.
Furthermore the central laboratory was placed around 300
meters away. If transport time to the central laboratory is
reduced this will reduce the difference in turnaround time
between POCT and central laboratory.
Conclusions
From our study we conclude, that fast laboratory answers
by POCT in an ED reduces the time to clinical decision
significantly for confirmed bacterial infections and suggest
further studies which include a sufficient number of
patients on deep venous thrombosis, acute appendicitis
and acute coronary syndrome.
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